Yale Study Finds Omega-3s Cut Pancreatic Cancer 50% as Oleic Acid Speeds Tumor Growth
Updated
Updated · ScienceDaily · Jun 2
Yale Study Finds Omega-3s Cut Pancreatic Cancer 50% as Oleic Acid Speeds Tumor Growth
2 articles · Updated · ScienceDaily · Jun 2
Fish-oil omega-3 diets cut pancreatic cancer development by 50% in mice predisposed to PDAC, while oleic-acid-rich diets accelerated tumor growth, Yale researchers reported in Cancer Discovery.
12 matched high-fat diets showed fat type—not calorie load—drove the difference: polyunsaturated fats increased vulnerability to ferroptosis, while monounsaturated oleic acid helped cancer cells resist oxidative death.
Male mice showed the strongest cancer-promoting response to oleic acid, whereas polyunsaturated fats reduced disease in both sexes.
PDAC kills more than 50,000 people a year in the U.S. and has a roughly 13% five-year survival rate, making diet-based prevention strategies a potential area for follow-up human research.
Could a simple blood test measuring your fat ratio soon predict your risk for this deadly cancer?
Does the 'healthiest' oil on the shelf actually fuel deadly pancreatic cancer, but only in men?
Rethinking Dietary Fats: New Evidence from Yale Links Fat Type to Pancreatic Cancer Risk and Sex Differences
Overview
A groundbreaking Yale study in April 2026 shifted the focus from total fat intake to the specific types of fats consumed and their impact on pancreatic cancer. While previous research produced conflicting results about different fatty acids, the Yale team used advanced mouse models to show that oleic acid, a monounsaturated fat, promoted tumor growth in males but not females. This highlighted important sex-based differences and the need for more precise dietary recommendations. Comprehensive meta-analyses now aim to clarify how monounsaturated, polyunsaturated, and saturated fats each influence pancreatic cancer risk, paving the way for more targeted prevention strategies.